The spread of a worldwide pandemic has brought an urgency for new healthcare technology around the globe. In fact, Forrester predicts more than 1 billion virtual visits to occur this year due to COVID-19, as well as regular healthcare maintenance, mental healthcare, flu treatment, and more.
As a result, companies are looking for new ways to help their healthcare provider clients tap into the latest tech innovations, particularly regarding data analytics and artificial intelligence (AI).
Accenture, which has been making deals throughout 2020, has decided to acquire OpusLine, a Paris-based consulting company that provides strategic advisory and transformational services to public- and private-sector healthcare providers, as well as life sciences and insurance companies in France. Financial terms have not been disclosed.
The deal will help Accenture provide its health industry clients with the latest technology in areas such as data analytics and AI, as well as support the health ecosystem with a variety of services.
“Our intent to acquire OpusLine is aligned with our development strategy and underscores our commitment to the health industry, which is a fast-growing sector for Accenture and also for society as a whole,” said Olivier Girard, Market Unit Lead for Accenture France & Benelux. “OpusLine’s extensive industry knowledge complements Accenture’s deep technology expertise and would provide our clients in France with even greater access to local and global industry expertise as they embrace new technologies and processes.”
Once the deal is completed, OpusLine’s employees will join the newly created health practice of Accenture Strategy & Consulting. This is the latest transaction in the healthcare- and life sciences-related fields by Accenture, including the 2019 acquisitions of Clarity Insights, Knowledgent, and Enterprise System Partners, and the 2017 acquisition of LabAnswer.
Accenture has had a busy 2020, even as it faced fallout from the COVID-19 pandemic. While the company’s full-year fiscal 2020 results were in line with expectations, its revenues for the full fiscal year increased only 3% in U.S. dollars compared with fiscal year 2019. Still, the company has invested nearly $1.5 billion globally on 34 acquisitions in its 2020 fiscal year, acquiring critical skills and capabilities in strategic, high-growth areas.